Best practice advice

Postpartum liver assessment is recommended for women with nonalcoholic fatty liver disease (NAFLD)

Routine screening of women with class III obesity for cholelithiasis every 5 years, post weight loss interventions (i.e. conservative, medical, or surgical management) that result in greater than 10% total body weight loss

In the absence of weight loss surgery, women living with obesity are at risk of micronutrient deficiency and may require nutritional assessment and supplementation

Annual screening for micronutrient deficiencies in women who have had weight loss surgery is recommended, with subsequent supplementation as needed. Screening for osteopenia and osteoporosis via bone density scan is recommended 1–2 years after malabsorptive weight loss surgery

Weight loss and specialized cancer screening are recommended to reduce the risk of obesity‐related cancers

Early assessment of women with obesity and abnormal uterine bleeding is recommended

Women living with obesity should be screened for impaired renal function by laboratory testing of estimated glomerular filtrate rate (eGFR), blood urea nitrogen (BUN), creatinine, and microalbuminuria at 3 months postpartum and at intervals up to 3–5 years postpartum

Assessment and treatment for obstructive sleep apnea is recommended for women to reduce health risks

Postpartum DVT prophylaxis is recommended for both cesarean and vaginal birth in women with obesity